Effect of levosimendan on hemodynamic changes in patients undergoing off-pump coronary artery bypass grafting: A randomized controlled study

Annals of Cardiac Anaesthesia

Volumn 16, Issue 2, 2013, Pages 94-99

  Kodalli, Rajesh ^a   Sundar, Ayya ^a   Vakamudi, Mahesh ^a   Ravulapali, Harish ^a   Nandipati, Sushma ^a   Chandrasekaran, Nivash ^a   Karthekeyan, Ranjith ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Cardiac index; Intensive care unit stay; Levosimendan; Systemic vascular resistance index

Indexed keywords

ANESTHETIC AGENT; LEVOSIMENDAN; NORADRENALIN; PLACEBO;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FUNCTIONAL ASSESSMENT; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; OFF PUMP CORONARY SURGERY; OPERATION DURATION; OUTCOME ASSESSMENT; OXYGEN SATURATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE INDEX;

CALCIUM; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS, OFF-PUMP; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; PYRIDAZINES;

EID: 84883247868     PISSN: 09719784     EISSN: 09745181     Source Type: Journal    
DOI: 10.4103/0971-9784.109737     Document Type: Article

References (25)

1. Chassot PG, van der Linden P, Zaugg M, Mueller XM, Spahn DR. Off-pump coronary artery bypass surgery: Physiology and anaesthetic management. Br J Anaesth 2004;92: 400-13.
2. Atasever B, Boer C, Speekenbrink R, Seyffert J, Goedhart P, de Mol B, et al. Cardiac displacement during off-pump coronary artery bypass grafting surgery: Effect on sublingual microcirculation and cerebral oxygenation. Interact Cardiovasc Thorac Surg 2011;13: 573-7.
3. George SJ, Al-Ruzzeh S, Amrani M. Mitral annulus distortion during beating heart surgery: A potential cause for hemodynamic disturbance-A three-dimensional echocardiography reconstruction study. Ann Thorac Surg 2002;73: 1424-30.
4. Mishra M, Malhotra R, Mishra A, Meharwal ZS, Trehan N. Hemodynamic changes during displacement of the beating heart using epicardial stabilization for off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002;16: 685-90.
5. Wu X, Bers DM. Sarcoplasmic reticulum and nuclear envelope are one highly interconnected Ca2+store throughout cardiac myocyte. Circ Res 2006;99: 283-91.
6. Lilleberg J, Nieminen MS, Akkila J, Heikkilä L, Kuitunen A, Lehtonen L, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998;19: 660-8.
7. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56: 978-85.
8. Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, et al. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990;15: 1261-9.
9. Ukkonen H, Saraste M, Akkila J, Knuuti MJ, Lehikoinen P, Någren K, et al. Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Ther 1997;61: 596-607.
10. Ukkonen H, Saraste M, Akkila J, Knuuti J, Karanko M, Iida H, et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000;68: 522-31.
11. Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 1997;333: 249-59.
12. Bowman P, Haikala H, Paul RJ. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther 1999;288: 316-25.
13. Gruhn N, Nielsen-Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 1998;31: 741-9.
14. Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003;107: 81-6.
15. McLean AS, Huang SJ, Nalos M, Ting I. Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic indices and B-type natriuretic peptide. J Cardiovasc Pharmacol 2005;46: 830-5.
16. Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 2000;36: 1903-12.
17. Kivikko M, Antila S, Eha J, Lehtonen L, Pentikäinen PJ. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. J Clin Pharmacol 2002;42: 43-51.
18. Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, et al. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Am J Cardiol 2006;98: 102-6.
19. Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K (ATP) channels. Anesth Analg 2000;90: 5-11.
20. Tritapepe L, De Santis V, Vitale D, Santulli M, Morelli A, Nofroni I, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-A pilot study. Br J Anaesth 2006;96: 694-700.
21. Auchampach JA, Maruyama M, Cavero I, Gross GJ. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 1992;86: 311-9.
22. Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006;59: 338-45.
23. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 2002;360: 196-202.
24. Moiseyev VS, Põder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002;23: 1422-32.
25. Sandell EP, Wesby-van-Swaay E, Poder P, T. Sarapohja, M.S. Nieminen, and L. Lehtonen. 341 A meta-analysis on the safety of the calcium sensitizing agent levosimendan. Eur J Heart Fail Suppl 2004;3: 86.